Bacterial Infections

  • Author: Harjot K. Singh, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/1/16 (What's New)

Summary

  • Guidelines on opportunistic infections recommend that bacillary angiomatosis, peliosis hepatitis, osteomyelitis, and Bartonella bacteremia be treated with macrolides or tetracyclines (Table 1) (Management Guidelines)[CDC OI]
    • In vitro sensitivity tests should not be used to guide antibiotic selection
    • Treatment should be continued until the CD4+ cell count has remained ≥ 200 cells/mm3 for ≥ 6 months

Action required

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.